Indian biopharmaceutical firm Biocon is likely to list its key biosimilars business by March 2026 and aims for double-digit share in its core U.S. market for its new launches, a top executive told ...

Gold prices surpassed the key $2,800 mark for the first time ever on Friday, fuelled by a rush to safety on U.S. President ...

India's fiscal deficit for April-December was 9.14 trillion rupees ($105.58 billion), or 56.7% of the estimate for the ...

Indian banks' loan growth moderated for a sixth straight month in December, central bank data showed on Friday, as the impact ...